Hakutulokset - Matthew J. Bott

Tarkenna hakua
  1. 1
    Pericardial effusions in the cancer population: Prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability

    Pericardial effusions in the cancer population: Prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability Tekijä Patrick Wagner, Eileen McAleer, Elizabeth E. Stillwell, Matthew J. Bott, Valerie W. Rusch, Wendy Schaffer, James Huang

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy

    Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy Tekijä Marie Brevet, Shigeki Shimizu, Matthew J. Bott, Neerav Shukla, Qin Zhou, Adam B. Olshen, Valerie W. Rusch, Marc Ladanyi

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations

    Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations Tekijä Marjorie G. Zauderer, Matthew J. Bott, Robert McMillan, Camelia S. Sima, Valerie W. Rusch, Lee M. Krug, Marc Ladanyi

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment

    New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment Tekijä Marc Ladanyi, Marjorie G. Zauderer, Lee M. Krug, Tatsuo Ito, Robert McMillan, Matthew J. Bott, Filippo G. Giancotti

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Management and Outcomes of Relapse After Treatment for Thymoma and Thymic Carcinoma

    Management and Outcomes of Relapse After Treatment for Thymoma and Thymic Carcinoma Tekijä Matthew J. Bott, Hanghang Wang, William D. Travis, Gregory J. Riely, Manjit S. Bains, Robert J. Downey, Valerie W. Rusch, James Huang

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?

    Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors? Tekijä Matthew J. Bott, Aalok Patel, Traves D. Crabtree, Graham A. Colditz, Daniel Kreisel, Alexander S. Krupnick, G. Alexander Patterson, Stephen Broderick, Bryan F. Meyers, Varun Puri

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis

    Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis Tekijä Takashi Eguchi, Koji Kameda, Shaohua Lu, Matthew J. Bott, Kay See Tan, Joseph Montecalvo, Jason C. Chang, Natasha Rekhtman, David R. Jones, William D. Travis, Prasad S. Adusumilli

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Early Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy

    Early Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy Tekijä Inderpal S. Sarkaria, Nabil P. Rizk, Debra A. Goldman, Camelia S. Sima, Kay See Tan, Manjit S. Bains, Prasad S. Adusumilli, Daniela Molena, Matthew J. Bott, Thomas M. Atkinson, David R. Jones, Valerie W. Rusch

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non–small cell lung cancer

    Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non–small cell lung cancer Tekijä M. Jawad Latif, Kay See Tan, Daniela Molena, James Huang, Matthew J. Bott, Bernard J. Park, Prasad S. Adusumilli, Valerie W. Rusch, Manjit S. Bains, Robert J. Downey, David R. Jones, James M. Isbell

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors

    Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors Tekijä Matthew J. Bott, Jonathan Cools‐Lartigue, Kay See Tan, Joseph Dycoco, Manjit S. Bains, Robert J. Downey, James Huang, James M. Isbell, Daniela Molena, Bernard J. Park, Valerie W. Rusch, Smita Sihag, David R. Jones, Prasad S. Adusumilli

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions

    Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions Tekijä Or Kalchiem‐Dekel, James G. Connolly, I‐Hsin Lin, Bryan Husta, Prasad S. Adusumilli, Jason Beattie, Darren J. Buonocore, Joseph Dycoco, Paige Fuentes, David R. Jones, Robert P. Lee, Bernard J. Park, Gaetano Rocco, Mohit Chawla, Matthew J. Bott

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma

    Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma Tekijä Arianna Barbetta, Meier Hsu, Kay See Tan, Dessislava Stefanova, Koby Herman, Prasad S. Adusumilli, Manjit S. Bains, Matthew J. Bott, James M. Isbell, Yelena Y. Janjigian, Geoffrey Y. Ku, Bernard J. Park, Abraham J. Wu, David R. Jones, Daniela Molena

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

    The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma Tekijä Matthew J. Bott, Marie Brevet, Barry S. Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard Lake, Maureen F. Zakowski, Boris Reva, Chris Sander, Robert Delsite, Simon N. Powell, Qin Zhou, Ronglai Shen, Adam B. Olshen, Valerie W. Rusch, Marc Ladanyi

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer

    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer Tekijä Matthew J. Bott, Stephen C. Yang, Bernard J. Park, Prasad S. Adusumilli, Valerie W. Rusch, James M. Isbell, Robert J. Downey, Julie R. Brahmer, Richard J. Battafarano, Errol L. Bush, Jamie E. Chaft, Patrick M. Forde, David R. Jones, Stephen Broderick

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma

    Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma Tekijä Neel P. Chudgar, Murray F. Brennan, Rodrigo Ramella Munhoz, Peter R. Bucciarelli, Kay See Tan, Sandra P. D’Angelo, Manjit S. Bains, Matthew J. Bott, James Huang, Bernard J. Park, Valerie W. Rusch, Prasad S. Adusumilli, William D. Tap, Samuel Singer, David R. Jones

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma

    The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma Tekijä Raul Caso, Francisco Sánchez-Vega, Kay See Tan, Brooke Mastrogiacomo, Jian Zhou, Gregory D. Jones, Bastien Nguyen, Nikolaus Schultz, James G. Connolly, Whitney S. Brandt, Matthew J. Bott, Gaetano Rocco, Daniela Molena, James M. Isbell, Yuan Liu, Marty W. Mayo, Prasad S. Adusumilli, William D. Travis, David R. Jones

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma

    Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma Tekijä James G. Connolly, Kay See Tan, Brooke Mastrogiacomo, Joseph Dycoco, Raul Caso, Gregory D. Jones, Patrick J. McCormick, Francisco Sánchez-Vega, Takeshi Irie, Joseph R. Scarpa, Hersh Gupta, Prasad S. Adusumilli, Gaetano Rocco, James M. Isbell, Matthew J. Bott, Gregory W. Fischer, David R. Jones, Joshua S. Mincer

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach

    Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Appro... Tekijä Jason C. Chang, Deepu Alex, Matthew J. Bott, Kay See Tan, Venkatraman Seshan, Andrew Golden, Jennifer L. Sauter, Darren J. Buonocore, Chad Vanderbilt, Sounak Gupta, Patrice Desmeules, Francis M. Bodd, Gregory J. Riely, Valerie W. Rusch, David R. Jones, Maria E. Arcila, William D. Travis, Marc Ladanyi, Natasha Rekhtman

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination

    NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination Tekijä Marcus Ruscetti, Josef Leibold, Matthew J. Bott, Myles Fennell, Amanda Kulick, Nelson R. Salgado, Chi-Chao Chen, Yu-Jui Ho, Francisco J. Sánchez‐Rivera, Judith Feucht, Timour Baslan, Sha Tian, Hsuan-An Chen, Paul B. Romesser, John T. Poirier, Charles M. Rudin, Elisa de Stanchina, Eusebio Manchado, Charles J. Sherr, Scott W. Lowe

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer

    Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer Tekijä Adam J. Schoenfeld, Hira Rizvi, Danish Memon, Narek Shaverdian, Matthew J. Bott, Jennifer L. Sauter, C. Jillian Tsai, Jayon Lihm, David Hoyos, Andrew J. Plodkowski, Rocío Pérez-Johnston, Peter Sawan, Jacklynn V. Egger, Benjamin D. Greenbaum, Andreas Rimner, Gregory J. Riely, Charles M. Rudin, Valerie W. Rusch, Daniel R. Gomez, Matthew D. Hellmann

    Julkaistu 2022
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: